Taro Pharmaceutical Industries Ltd. TARO
$ 42.97
0.0%
Annual report 2022
added 07-25-2022
Country |
Israel |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NYSE |
CEO |
Mr. Uday Baldota |
Employees in the company |
1 464 |
Shares |
37.6 M |
Market Cap[1] |
$ 1.62 B |
EBITDA (LTM) |
$ 109 M |
P/E (LTM) |
18.29 |
P/S (LTM) |
4.46 |
EPS (LTM) |
1.64 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.